J3371 – Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ3371
- Long description
- Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg
- Short description
- Inj, vancomycin hcl (mylan)
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 2023
- Last change
- July 1, 2025 – No change
- Termination date
- June 30, 2025
Frequently asked questions
What is HCPCS code J3371?
J3371 is a HCPCS Level II code for injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg. It was discontinued on June 30, 2025.
Does Medicare cover J3371?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J3350 – Injection, urea, up to 40 gm
- J3355 – Injection, urofollitropin, 75 iu
- J3357 – Ustekinumab, for subcutaneous injection, 1 mg
- J3358 – Ustekinumab, for intravenous injection, 1 mg
- J3360 – Injection, diazepam, up to 5 mg
- J3364 – Injection, urokinase, 5000 iu vial
- J3365 – Injection, iv, urokinase, 250,000 i.u. vial
- J3370 – Injection, vancomycin hcl, 500 mg
- J3372 – Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg
- J3373 – Injection, vancomycin hydrochloride, 10 mg
- J3374 – Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg
- J3375 – Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
- J3376 – Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg
- J3379 – Injection, valproate sodium, 5 mg
- J3380 – Injection, vedolizumab, intravenous, 1 mg
- J3385 – Injection, velaglucerase alfa, 100 units
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.